Literature DB >> 9861831

Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia.

L B Johnson1, S F Bradley, C A Kauffman.   

Abstract

Cryptococcus laurentii is one of several non-neoformans cryptococci that have rarely been associated with human infection. The spectrum of clinical infection due to non-neoformans species ranges from skin lesions to fungaemia. Most cases of non-neoformans fungaemia have been nosocomially acquired and have been associated with indwelling intravascular catheters and neutropenia. Limited data on in vitro susceptibilities of non-neoformans cryptococci show these species to be more resistant to fluconazole and flucytosine than most Cr. neoformans. Two such cases are presented here.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861831     DOI: 10.1111/j.1439-0507.1998.tb00338.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  23 in total

1.  In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts.

Authors:  Carolina Serena; Francisco Javier Pastor; Montserrat Ortoneda; Javier Capilla; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

2.  Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS.

Authors:  Esaki Muthu Shankar; Nagalingeswaran Kumarasamy; Devaleenol Bella; Srinivasan Renuka; Hayak Kownhar; Solomon Suniti; Ramachandra Rajan; Usha Anand Rao
Journal:  Can Respir J       Date:  2006 Jul-Aug       Impact factor: 2.409

3.  Intraspecies diversity of Cryptococcus laurentii as revealed by sequences of internal transcribed spacer regions and 28S rRNA gene and taxonomic position of C. laurentii clinical isolates.

Authors:  T Sugita; M Takashima; R Ikeda; T Nakase; T Shinoda
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil.

Authors:  Kennio Ferreira-Paim; Leonardo Andrade-Silva; Delio Jose Mora; Eliane Lages-Silva; André Luiz Pedrosa; Paulo Roberto da Silva; Anderson Assunção Andrade; Mario León Silva-Vergara
Journal:  Mycopathologia       Date:  2011-11-25       Impact factor: 2.574

5.  Cryptococcus laurentii biofilms: structure, development and antifungal drug resistance.

Authors:  K Ajesh; K Sreejith
Journal:  Mycopathologia       Date:  2012-09-01       Impact factor: 2.574

6.  Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patient.

Authors:  T G M Bauters; D Swinne; T Boekhout; L Noens; H J Nelis
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

7.  Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans.

Authors:  Reiko Ikeda; Takashi Sugita; Eric S Jacobson; Takako Shinoda
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

8.  In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.

Authors:  Carolina Serena; Belkys Fernández-Torres; F Javier Pastor; Luciana Trilles; Márcia Dos Santos Lazéra; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Presence of C. albidus, C. laurentii and C. uniguttulatus in crop and droppings of pigeon lofts (Columba livia).

Authors:  I Rosario; G Soro; S Déniz; O Ferrer; F Acosta; D Padilla; B Acosta
Journal:  Mycopathologia       Date:  2009-12-10       Impact factor: 2.574

10.  Occurrence of yeasts in cloacae of migratory birds.

Authors:  C Cafarchia; A Camarda; D Romito; M Campolo; N C Quaglia; D Tullio; D Otranto
Journal:  Mycopathologia       Date:  2006-04       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.